Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Immunovant, Inc. - Common Stock
(NQ:
IMVT
)
25.59
+0.17 (+0.67%)
Streaming Delayed Price
Updated: 1:56 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunovant, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
HC Wainwright & Co. Maintains Buy Rating for Immunovant: Here's What You Need To Know
↗
May 23, 2023
Via
Benzinga
Immunovant Inc. (NASDAQ: IMVT) is a Stock Spotlight on 5/23
May 23, 2023
Via
Investor Brand Network
Analyst Expectations for Immunovant's Future
↗
May 23, 2023
Via
Benzinga
Recap: Immunovant Q4 Earnings
↗
May 22, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023
↗
May 01, 2023
Via
Benzinga
Analyst Expectations for Immunovant's Future
↗
April 25, 2023
Via
Benzinga
7 Analysts Have This to Say About Immunovant
↗
March 30, 2023
Via
Benzinga
Immunovant Inc. (NASDAQ: IMVT) is a Stock Spotlight on 3/24
March 24, 2023
Via
Investor Brand Network
Analyst Boosts Immunovant Price Target After Updated Pipeline Realignment
↗
March 20, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2023
↗
April 25, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
↗
March 31, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
↗
March 30, 2023
Via
Benzinga
Immunovant Could Potentially Be An M&A Target, Writes Analyst
↗
February 15, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023
↗
February 15, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023
↗
February 13, 2023
Via
Benzinga
Analyst Expectations for Immunovant's Future
↗
February 07, 2023
Via
Benzinga
Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector
↗
December 23, 2022
The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
What 6 Analyst Ratings Have To Say About Immunovant
↗
November 08, 2022
Within the last quarter, Immunovant (NASDAQ:IMVT) has observed the following analyst ratings:
Via
Benzinga
6 Analysts Have This to Say About Immunovant
↗
November 08, 2022
Over the past 3 months, 6 analysts have published their opinion on Immunovant (NASDAQ:IMVT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Where Immunovant Stands With Analysts
↗
November 07, 2022
Immunovant (NASDAQ:IMVT) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Immunovant to Present at Guggenheim 4th Annual Immunology and Neurology Day on November 14th
November 07, 2022
From
Immunovant Inc.
Via
GlobeNewswire
Immunovant: Q2 Earnings Insights
↗
November 04, 2022
Immunovant (NASDAQ:IMVT) reported its Q2 earnings results on Friday, November 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Immunovant Stock Is Skyrocketing This Week
↗
October 06, 2022
The drugmaker announced a $75 million public offering.
Via
The Motley Fool
Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended September 30, 2022
November 04, 2022
From
Immunovant Inc.
Via
GlobeNewswire
Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday
↗
October 06, 2022
Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday.
Via
Benzinga
Why Sotera Health Shares Are Trading Lower By Around 13%, Here Are 38 Stocks Moving In Wednesday's Mid-Day Session
↗
October 05, 2022
Gainers Pineapple Energy Inc. (NASDAQ: PEGY) shares jumped 104% to $2.9201. Shares of this low-float penny stock closed up about 80% on Tuesday.
Via
Benzinga
RPM International, Lamb Weston And Some Other Big Stocks Moving Higher On Wednesday
↗
October 05, 2022
U.S. stocks traded lower, with the Dow Jones dropping more than 300 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
S&P 500 Rises 100 Points; Nasdaq Up 3%
↗
October 04, 2022
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing more than 300 points on Tuesday.
Via
Benzinga
R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing
October 05, 2022
Palm Beach, FL – October 5, 2022 – FinancialNewsMedia.com News Commentary – Advanced pancreatic ductal adenocarcinoma (PDAC) remains a significant cause of mortality accounting for up to 4% of all...
Via
FinancialNewsMedia
Topics
Death
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
October 04, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
